Atypical Chronic Myeloid Leukemia, BCR-ABL Negative: Clinical Trials

5 trials for Atypical Chronic Myeloid Leukemia, BCR-ABL Negative, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated, 1 active not recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Not applicable1Terminated 1
Phase 31Completed 1

Follow Atypical Chronic Myeloid Leukemia, BCR-ABL Negative: new trials by email Literature Review of Atypical Chronic Myeloid Leukemia, BCR-ABL Negative trials Research Report on Atypical Chronic Myeloid Leukemia, BCR-ABL Negative

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
infection prophylaxis and management, laboratory biomarker analysis, flow cytometry - Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia
Active not recruitingCity of Hope Medical Center1532011-01-112026-10-22
Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload
deferasirox - Iron Overload, Accelerated Phase Chronic Myelogenous Leukemia
Phase 2TerminatedCity of Hope Medical Center12010-07-012019-06-18
Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
plerixafor, filgrastim, peripheral blood stem cell transplantation - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Not applicableTerminatedFred Hutchinson Cancer Center12010-06-012017-06-28
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant
ondansetron, survey administration, management of therapy complications - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 2CompletedFred Hutchinson Cancer Center492008-08-082017-05-23
Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications
internet-based intervention, questionnaire administration, psychosocial assessment and care - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 3CompletedFred Hutchinson Cancer Research Center/University of Washington Cancer Consortium13372008-08-012012-03-07

Narrower conditions

Blast Crisis (5)  ·  Burkitt Lymphoma (5)  ·  Congenital Abnormalities (5)  ·  Hodgkin Disease (5)  ·  Leukemia, Hairy Cell (5)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (5)  ·  Leukemia, Myeloid, Accelerated Phase (5)  ·  Leukemia, Myeloid, Acute (5)  ·  Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (5)  ·  Leukemia, Myeloid, Chronic-Phase (5)  ·  Lymphoma, B-Cell, Marginal Zone (5)  ·  Lymphoma, Follicular (5)  ·  Lymphoma, Large B-Cell, Diffuse (5)  ·  Lymphoma, Large-Cell, Immunoblastic (5)  ·  Lymphoma, Mantle-Cell (5)

Broader conditions

Blood Protein Disorders (5)  ·  Bone Marrow Diseases (5)  ·  Carcinogenesis (5)  ·  Cardiovascular Diseases (5)  ·  Cell Transformation, Neoplastic (5)  ·  Chronic Disease (5)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  DNA Virus Infections (5)  ·  Disease Attributes (5)  ·  Epstein-Barr Virus Infections (5)  ·  Hematologic Diseases (5)  ·  Hemic and Lymphatic Diseases (5)  ·  Hemorrhagic Disorders (5)  ·  Hemostatic Disorders (5)  ·  Herpesviridae Infections (5)

Interventions

Therapeutics (2)  ·  Antiviral Agents (1)  ·  Counseling (1)  ·  Deferasirox (1)  ·  Filgrastim (1)  ·  Flow Cytometry (1)  ·  Foscarnet (1)  ·  Ganciclovir (1)  ·  Granulocyte Colony-Stimulating Factor (1)  ·  Ondansetron (1)  ·  Peripheral Blood Stem Cell Transplantation (1)  ·  Polymerase Chain Reaction (1)  ·  Psychiatric Rehabilitation (1)  ·  Valganciclovir (1)  ·  plerixafor (1)

Sponsors

City of Hope Medical Center (2)  ·  Fred Hutchinson Cancer Center (2)  ·  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium (1)

Countries

United States (5)

Top investigators

Karen Syrjala (1)  ·  Leona Holmberg (1)  ·  Ryotaro Nakamura (1)  ·  Vinod Pullarkat, MD (1)  ·  William Bensinger (1)

Results publications

PMID 32628342, PMID 33420905, PMID 36282798

NIH funding

R01CA112631 (1)